Clinical Significance of Natriuretic Peptides and Cyclic GMP in Hemodialysis Patients with Coronary Artery Disease

Publisher： Karger

E-ISSN： 1421-9670|21|2|112-119

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.21, Iss.2, 2001-05, pp. : 112-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of Plasma Levels of Mature Adrenomedullin and Natriuretic Peptide as Markers of Cardiac Function in Hemodialysis Patients with Coronary Artery Disease

By  

Nephron, Vol. 92, Iss. 4, 2002-10 ,pp. : 832-839

Karger

Access to resources Recommend Favorite

Serum Malondialdehyde and Coronary Artery Disease in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 24, Iss. 5, 2004-12 ,pp. : 537-542

Karger

Access to resources Recommend Favorite

The Prognostic Role of Brain Natriuretic Peptides in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 22, Iss. 5-6, 2002-10 ,pp. : 437-444

Karger

Access to resources Recommend Favorite

The Prognostic Role of Atrial Natriuretic Peptides in Hemodialysis Patients

By  

Blood Purification, Vol. 21, Iss. 6, 2003-11 ,pp. : 395-400

Karger

Access to resources Recommend Favorite

Assessment of Coronary Artery Disease in Hemodialysis Patients with Delayed Systolic Blood Pressure Response after Exercise Testing

By  

Blood Purification, Vol. 23, Iss. 6, 2005-12 ,pp. : 466-472

Karger

Access to resources Recommend Favorite